Patterns and outcomes of drug-eluting coronary stent use in clinical practice
Authors:
- Sunil V. RaoSRSunil V. Rao
- Richard E. ShawRSRichard E. Shaw
- Ralph G. BrindisRBRalph G. Brindis
- Lloyd W. KleinLKLloyd W. Klein
- William S. WeintraubWWWilliam S. Weintraub
- Ronald J. KroneRKRonald J. Krone
- Eric D. PetersonEPEric D. Peterson
- 1 August 2006
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 152 (2) , 321-326
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Trends in implantable cardioverter-defibrillator racial disparityJACC, 2005
- Antithrombotic Therapy During Percutaneous Coronary InterventionChest, 2004
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV–ACSAmerican Heart Journal, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Racial Disparity in Cardiac Procedures and Mortality Among Long-Term Survivors of Cardiac ArrestCirculation, 2003
- Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart DiseaseNew England Journal of Medicine, 2002
- The American College of Cardiology-National Cardiovascular Data Registry™ (ACC-NCDR™): building a national clinical data repositoryJACC, 2001